Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
350 studies found for:    Open Studies | antidepressants
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | antidepressants
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Tapering Off Antidepressants
Conditions: Major Depressive Disorder;   Anxiety Disorder;   Obsessive Compulsive Disorder;   Post-Traumatic Stress Disorder
Interventions: Other: Two-Week Antidepressant Taper Regimen;   Other: One-Week Antidepressant Taper Regimen
2 Recruiting Antidepressant Response in the Treatment of Depressive Symptoms and Frailty Characteristics in Older Adults
Conditions: Major Depressive Disorder;   Dysthymic Disorder;   Depressive Disorder, NOS
Intervention: Drug: Antidepressant Medication
3 Recruiting Evaluation of the Efficacy of Serotoninergic Antidepressants in Bulimia Nervosa, According to Brain Serotonin Profile Determined by Positron Emission Tomography With [18F] MPPF.
Condition: Bulimia Nervosa
Interventions: Drug: Antidepressants;   Drug: Positron Emission Tomography (PET)
4 Recruiting Predictors of Antidepressant Response
Condition: Depression
Interventions: Other: Placebo;   Drug: Citalopram, or other antidepressant as clinically indicated
5 Recruiting A Study to Evaluate the Efficacy, Safety, and Tolerability of Intranasal Esketamine Plus an Oral Antidepressant in Elderly Participants With Treatment-resistant Depression
Condition: Depressive Disorder, Treatment-Resistant
Interventions: Drug: Esketamine;   Drug: Placebo;   Drug: Duloxetine (Oral Antidepressant);   Drug: Escitalopram (Oral Antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (New Antidepressant)
6 Recruiting A Study of Intranasal Esketamine Plus an Oral Antidepressant for Relapse Prevention in Adult Participants With Treatment-resistant Depression
Condition: Depressive Disorder, Treatment-Resistant
Interventions: Drug: Esketamine;   Drug: Placebo;   Drug: Duloxetine (Oral Antidepressant);   Drug: Escitalopram (Oral antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (Oral Antidepressant)
7 Recruiting A Study to Evaluate the Efficacy, Safety, and Tolerability of Flexible Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Condition: Treatment-resistant Depression
Interventions: Drug: Esketamine;   Drug: Placebo;   Drug: Duloxetine (Oral Antidepressant);   Drug: Escitalopram (Oral antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (Oral Antidepressant)
8 Recruiting A Study to Evaluate the Efficacy, Safety, and Tolerability of Fixed Doses of Intranasal Esketamine Plus an Oral Antidepressant in Adult Participants With Treatment-resistant Depression
Condition: Treatment-resistant Depression
Interventions: Drug: Esketamine;   Drug: Placebo;   Drug: Duloxetine (Oral Antidepressant);   Drug: Escitalopram (Oral antidepressant);   Drug: Sertraline (Oral Antidepressant);   Drug: Venlafaxine Extended Release (XR) (Oral Antidepressant)
9 Recruiting Patient Decision Aid for Antidepressant Use in Pregnancy
Conditions: Pregnancy;   Depression
Interventions: Behavioral: Electronic Patient Decision Aid;   Behavioral: Standard Resource Sheet
10 Recruiting A Study of Chinese Medicine Treating Depression
Condition: Depression
Interventions: Drug: Traditional Chinese Medicine;   Drug: Antidepressants
11 Not yet recruiting Multimodal Imaging of ECT Effects
Condition: Major Depressive Disorder
Interventions: Procedure: electroconvulsive therapy;   Drug: Antidepressant
12 Recruiting Genecept Assay and Adverse Effects of Antidepressants
Conditions: Depression;   Adverse Effects
Intervention: Genetic: Genocept Assay
13 Recruiting Antidepressants During Pregnancy and Lactation: Pharmacokinetics and Clinical Implications
Conditions: Depressive Disorder;   Lactation
Intervention: Drug: SSRI/SNRI
14 Recruiting Patient Decision Aid for Antidepressant Use in Pregnancy
Conditions: Depression;   Pregnancy
Interventions: Behavioral: Standard Resource Sheet;   Behavioral: Patient Decision Aid
15 Recruiting Predictors of the Outcome of Late Life Depression
Condition: Major Depression
Interventions: Drug: Antidepressant;   Other: Psychoeducation;   Other: Treatment as usual (only pharmacological treatment).
16 Recruiting Tibolone and Placebo in Adjunct to Antidepressant Medication for Women With Menopausal Depression
Condition: Menopausal Depression
Intervention: Drug: Tibolone
17 Not yet recruiting Personalized Indications for CBT and Antidepressants in Treating Depression
Conditions: Major Depressive Disorder;   Persistent Depressive Disorder
Interventions: Behavioral: Cognitive Behavioral Therapy;   Drug: Pharmacotherapy
18 Recruiting Mood Stabilizer (MS)+ Antidepressant vs MS + Placebo in Maintenance of Bipolar Disorder.
Condition: Bipolar I Disorder
Interventions: Drug: Escitalopram;   Drug: Wellbutrin XL
19 Recruiting Pharmacogenomic Study to Predict Antidepressant Responsiveness in Depressed Patients
Conditions: Depression;   Adverse Reaction to Drug
Interventions: Drug: SSRI treated group;   Drug: non-SSRI treated group
20 Recruiting Efficacy of Trial-Based Cognitive Therapy and Behavioral Activation in Treatment of Depression
Condition: Major Depressive Disorder
Interventions: Behavioral: Trial based cognitive therapy;   Behavioral: Behavioral Activation;   Drug: Antidepressants

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.